Back

Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Rey Adam Cordovez

Vicente Sotto Memorial Medical Center, Cebu City (Philippines)

2 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials
Assistant Professor P. Sharma (Lucknow, IN)
Abstract Slides
Presentation thumbnail
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2
Mr H. Hermawan (Surabaya, ID)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and Pharmacotherapy

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources